Contact us now (917) 414-8695

Advisory Board



Dr. Lois Jovanovič In addition to her position as CEO & Chief Scientific Officer of Sansum Diabetes Research Institute, Dr. Jovanovič is a Clinical Professor of Medicine, University of Southern California-Keck School of Medicine, and Adjunct Professor of Biomolecular Science and Engineering and Chemical Engineering, University of California-Santa Barbara. Dr. Jovanovič completed her undergraduate degree from Columbia University, and a master’s degree in Hebrew Literature from The Jewish Theological Seminary in New York, NY. She received her medical degree from The Albert Einstein College of Medicine in New York, NY, and completed her training and fellowship in Internal Medicine, Endocrinology and Metabolism at the New York Hospital, Cornell University Medical College. Jovanovič’s pioneering work in diabetes and pregnancy began with her premise that a diabetic woman’s chances of having a healthy baby could be on a par with a healthy, non-diabetic woman. In her beginning year of fellowship at Cornell University, New York Hospital, her first research study showed that strict monitoring and absolute normalization of blood glucose could yield healthy babies. A year later, she published a larger trial of 52 diabetic women that showed conclusively that diabetic women, even those with severe disease, could have healthy babies (Am J Med 1981; 71: 921–27). Jovanovič proceeded to develop a program to monitor a woman’s blood glucose around the clock and provide treatment strategies to achieve and maintain normal blood glucose concentrations throughout pregnancy. These protocols for intensive insulin delivery now set the standard for strict glucose control in pregnancy. For the past 13 years Jovanovič has been CEO & Chief Scientific Officer of Sansum Diabetes Research Institute. Under her leadership, the Institute has become a center of excellence for diabetes and pregnancy. Through community outreach education, teaching and working one-on-one with thousands of pregnant women in the Latina population, she has changed the world of diabetes and pregnancy. She is responsible for establishing global guidelines of care adopted by the International Diabetes Federation and travels extensively throughout the world teaching her protocols to physicians, nurses, dietitians, and educators. In December 2009 she attended the opening of the new Bildirici Center for Diabetes Care and Research in Netanya, Israel where all of their nurses had been trained in her protocols. Throughout her research Dr. Jovanovič has continued to focus on how understanding diabetes in pregnant women may help to broaden knowledge and treatment options for all people with diabetes. Always in the forefront of research, Dr. Jovanovic and other staff members are currently working on the development of an artificial pancreas in collaboration with the Department of Chemical Engineering at the University of California Santa Barbara. Clinical trials began in 2011.

Lydia Fazzio, MD, has worked in healthcare communications for almost 10 years, and has helped craft medical strategy for more than 15 pharmaceutical brands, including the sanofi-aventis diabetes portfolio (Apidra, Lantus and Lixisenatide). She specializes in generating market/product assessments and designing brand narratives and communication strategies for pre and post-launch brands, with a specific expertise in direct-to-professional communications. In her past, Lydia was in the medical affairs division of Ortho-McNeil, where she explored novel uses for the anticonvulsant Topamax, including cardiometabolic applications. As a clinical research physician on the global Zyprexa team at Eli Lilly, she worked on the design and implementation of phase III/IV trials and participated in pharmacovigilance reviews of the Zyprexa metabolic profile. She also worked with internal statistics and medical-marketing teams to conduct analyses that guided corporate responses to queries by national and international regulatory authorities. Lydia is also the creator of BiohackersNYC. Biohacking, for those unfamiliar, is the concept that our brain and body functioning, like software/hardware, can be 'enhanced' to a more optimized individual baseline. BioHackersNYC was created to bring multidisciplinary perspectives on the practice. Lydia earned her medical degree from Tufts University School of Medicine and completed a clinical fellowship in medicine/psychiatry at Harvard University School of Medicine. She was a psychopharmacologist at Bellevue Hospital in New York and has held academic appointments as an assistant professor of psychiatry at NYU School of Medicine.

Joy Pape has over 30 years experience as an RN, and has been Certified Diabetes Educator for more than 20 years. Her focus is on weight management, healthy eating, self-monitoring, healthy coping, integrative therapies, insulin pump training (certified pump trainer), continuous glucose monitoring, and foot care (board certified foot care nurse). She provides diabetes education to individuals and groups in physicians’offices, pharmacies, telehealth, and large groups throughout the US. She has worked as a consultant for: Novo Nordisk, Omron Healthcare, Tolerx (DEFEND Studies), Abbott Diabetes Care, Medtronic MiniMed, OmniPod, Duane Reade (CDE for group classes, developed curriculum and provided the actual teaching), Divabetic Organization- (Lead CDE/Support Group Leader), dLife TV- (contributing medical producer, frequent guest). She is also a prolific writer on diabetes for: Novo Nordisk, J & J, Walgreen’s (Diabetes and You Magazine), Diabetic Living, Diabetes Self-Management, and Diabetes Health. She is co-author of the Real Life Guide to Diabetes, published by the American Diabetes Association. Finally, she is President of the Metro NY Chapter of the American Association of Diabetes Educators and former President of the Central Missouri Chapter of the Association of Diabetes Educators.

David Kliff is an insulin-using Type 2, who was diagnosed at the age of 36. After his diagnosis, Kliff set out to learn everything he could about the disease he would have for the rest of his life. A Registered Investment Advisor Kliff quickly realized the investment potential within the diabetes industry and turned his diabetes diagnosis into an investment opportunity. He began publishing the Diabetic Investor 10 years ago, when the publishing the world was a very different place. The Diabetic Investor literally blazed the trail–there were no other information portals or media outlets devoted exclusively to the business of diabetes. Sensing a huge investment opportunity, Kliff believed that his investment clients would profit by investing in companies that were leaders in the diabetes sector. Unfortunately, the investment research on many of these companies fell short on two fronts: either the company was not being followed, or the analysis that was done did not understand the world of diabetes and therefore led to flawed conclusions. It was here that Diabetic Investor was born. Living with diabetes, Kliff not only used many of the products, but he understood the psychological impact of diabetes. This perspective proved to be invaluable when analyzing the many companies involved in the diabetes sector. After he began publishing, Diabetic Investor quickly became the leading source of information on the diabetes sector. Featured in The Wall Street Journal, The Washington Post, Money magazine, Forbes, Technology Investor, and many others, Diabetic Investor has been recognized as the number one source of research when it comes to the business of diabetes. Today, Kliff, who is married and also has a talent for cooking, dedicates his full-time attention to Diabetic Investor and has sold his money management firm. You can read and subscribe to Diabetic Investor at www.diabeticinvestor.com.

Melissa Ford Holloway has worked in diabetes care devices and healthcare communications for a decade. In 2002, as a graduate student in early modern British history at Oxford University, she founded a peer support network for fellow students with Type 1 diabetes. Overwhelmed by the positive response to her column on insulin pump therapy for Mmedscape in 2003, Melissa left her doctoral program to pursue opportunities in the diabetes care industry. She built her expertise in diabetes, diabetes management and the business of diabetes through part-time work for a diabetes-focused research consultancy (2003-2005). She then moved to Abbott Diabetes Care, where she worked in operations from 2005-2007. While at Abbott, Melissa published several freelance magazine articles on diabetes. She returned to the UK in 2007 and joined Datamonitor as a healthcare business consultant, where she worked on products ranging from probiotics to biosimilars, and on disease areas from psoriasis to cardiovascular disease. In 2009 she turned her passion for healthcare to advertising. Melissa is now a medical copywriter at TBWA\Paling Walters in London, with an emphasis on healthcare professional sales materials in several secondary care areas. She thrives on translating scientific data into compelling, strategically sound communications. She has developed continuing professional education on insulin pump therapy and diabetes and exercise. Outside of work, Melissa is an advocate for access to diabetes technology in the UK with INPUT (http://www.input.me.uk) and a volunteer for JDRF.